Refine by
Inflammatory Mediator Suppliers Serving Mongolia
9 companies found
based inSão Paulo, BRAZIL
We were born on July, 15, 1994 in Amparo/SP, and the essence of our company is to use state-of -the-art technology to develop equipment for human wellness, in physical rehabilitation, esthetics or esthetic medicine. Today, we are located in a built ...
based inDeerfield, ILLINOIS (USA)
Baxter was founded in 1931, however our history doesn't have one starting point. Our commitment to addressing unmet needs was built on the shoulders of healthcare pioneers whose work resulted in first-of-its-kind innovations in IVs, renal care, ...
The Oxiris set is available in select countries around the world. Oxiris is the only blood purification filter set to effectively remove inflammatory mediators, endotoxin, fluid, and uremic toxins simultaneously. ...
based inMonmouth Junction, NEW JERSEY (USA)
CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 58 countries around the world, as an extracorporeal ...
The CytoSorb adsorber is a CE-marked Class IIb medical device that is specifically approved for the removal of cytokines, bilirubin and myoglobin. Next to this CytoSorb is indicated for use intraoperatively during cardio-pulmonary bypass surgery for ...
based inMeinier, SWITZERLAND
Infomed is a Swiss company based in Geneva dedicated to the development and manufacturing of blood purification devices since 1997. Our products are applicable to nephrology, intensive care, hematology and cardiology. Infomed has been, for more than ...
In ICUs, HemoFiltration (HF) is usually indicated in case of Fluid overload, Congestive heart failure, Acute renal failure, Crush syndrome, Lactic acidosis … . But HF may also be successfully used for patients with chronic renal failure. This ...
based inWayne, PENNSYLVANIA (USA)
Sino Biological is committed to providing high-quality recombinant protein and antibody reagents and to being a one-stop technical services shop for life science researchers around the world. All of our products are independently developed and ...
FCAR, also called FcαRI or CD89, is a type I transmembrane receptor for Fc region of IgA which is the most abundant immunoglobulin in mucosal areas but is only the second most common antibody isotype in serum. This receptor is present on the ...
based inTienen, BELGIUM
As the pioneer of hemodialysis machines in Japan, the Nikkiso Medical Division continues to improve dialysis medical care and patient QOL. Part of the Nikkiso Group, our Medical division can look back on a company history of more than half a ...
One advanced Polyethersulphone membrane in a range of sizes. Engineered for all CRRT patient requirements. Truly one filter type for all CRRT ...
based inOklahoma City, OKLAHOMA (USA)
By launching first-in-market biomarker tests and developing digital biomarkers for the continuous monitoring of disease, we support clinicians in their effort to provide exceptional care. Our technologies will empower clinician decision making and ...
Immunological insights for proactive lupus care; Get started today with aiSLE DX Flare Risk Index, a new blood test that identifies a SLE patient's future risk of a lupus ...
based inKarlsruhe, GERMANY
The physical dimensions and ergonomic design of office medical equipment is often the key to a swift, economic and safe work process. CRYOFOS has been designed with the typical requirements of in-office work in mind. The operating elements are ...
Cryostimulation, as a method of stimulating the body´s own neuroreflexive responses to combat pain and is a todays technique of choice fort he daily treatments of accute or chronic ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
RVX-297 is a potent, orally active BET bromodomain inhibitor with selectivity for BD2. RVX-297 shows IC50s of 0.08, 0.05, and 0.02 μM for BRD2(BD2), BRD3(BD2), and BRD4(BD2), respectively. RVX-297 suppresses inflammatory gene expression in multiple ...